Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma

Kidney renal papillary cell carcinoma (KIRP) has a high mortality rate and a poor prognosis. Cu concentrations differed significantly between renal cancer tissues and adjacent normal tissues. Cuproptosis is a newly identified cell death. Long non-coding RNAs (lncRNAs) play a crucial role in the prog...

Podrobná bibliografie
Hlavní autoři:	Tongjin Xie, Bin Liu, Dongbo Liu, Yusong Zhou, Qingping Yang, Dai Wang, Mengjie Tang, Wei Liu
Médium:	Článek
Jazyk:	English
Vydáno:	Frontiers Media S.A. 2022-12-01
Edice:	Frontiers in Pharmacology
Témata:	lncRNA cuproptosis KIRP prognosis immune relevance
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1103986/full

Podobné jednotky

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
Autor: Yuchen Bai, a další
Vydáno: (2022-11-01)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
Autor: Mingyi Yang, a další
Vydáno: (2022-07-01)

Ferroptosis-Related lncRNA to Predict the Clinical Outcomes and Molecular Characteristics of Kidney Renal Papillary Cell Carcinoma
Autor: Yubo Gong, a další
Vydáno: (2024-02-01)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
Autor: Binfeng Liu, a další
Vydáno: (2022-10-01)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
Autor: Jingyi Wu, a další
Vydáno: (2023-09-01)

Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity
Autor: Ziwei Gao, a další
Vydáno: (2025-01-01)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
Autor: Pengpeng Zhang, a další
Vydáno: (2023-01-01)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
Autor: Yifan Xu, a další
Vydáno: (2022-10-01)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
Autor: Youlong Huili, a další
Vydáno: (2022-08-01)

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
Autor: Xiaojing Yang, a další
Vydáno: (2022-09-01)

Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer
Autor: Jia Chen, a další
Vydáno: (2022-12-01)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
Autor: Zhixun Bai, a další
Vydáno: (2022-12-01)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
Autor: Zi-Rong Jiang, a další
Vydáno: (2022-09-01)

Identification of a novel prognostic cuproptosis-associated LncRNA signature for predicting prognosis and immunotherapy response in patients with esophageal cancer
Autor: Xinhai Sun, a další
Vydáno: (2024-05-01)

Prognostic Significance and Immune Landscape of a Cuproptosis-Related LncRNA Signature in Ovarian Cancer
Autor: Min Zhou, a další
Vydáno: (2024-11-01)

A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
Autor: Zheng Zhou, a další
Vydáno: (2023-03-01)

In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma
Autor: Yue Wang, a další
Vydáno: (2022-09-01)

Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma
Autor: Shusheng Zhu, a další
Vydáno: (2023-07-01)

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
Autor: Binfeng Liu, a další
Vydáno: (2022-12-01)

Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer
Autor: Chun Li, a další
Vydáno: (2023-07-01)

Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia
Autor: Yidong Zhu, a další
Vydáno: (2023-02-01)

Development and validation of a cuproptosis-related lncRNA model correlated to the cancer-associated fibroblasts enable the prediction prognosis of patients with osteosarcoma
Autor: Xiaoping Wang, a další
Vydáno: (2023-02-01)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
Autor: Jun Wen, a další
Vydáno: (2023-01-01)

Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphoma
Autor: Xiaoran Bai, a další
Vydáno: (2024-06-01)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
Autor: Miaorong Xu, a další
Vydáno: (2022-07-01)

Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer
Autor: Xinyu Liu, a další
Vydáno: (2022-09-01)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
Autor: Hui Chen, a další
Vydáno: (2023-01-01)

Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer
Autor: Xiajing Liu, a další
Vydáno: (2022-11-01)

Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer
Autor: Li Liu, a další
Vydáno: (2023-01-01)

Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs
Autor: Mingwei Wei, a další
Vydáno: (2024-04-01)

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
Autor: Chao Ma, a další
Vydáno: (2023-02-01)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
Autor: Shengxian Xu, a další
Vydáno: (2022-07-01)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
Autor: Chong Li, a další
Vydáno: (2023-06-01)

Prediction of immune infiltration and prognosis for patients with cholangiocarcinoma based on a cuproptosis-related lncRNA signature
Autor: Hong-Fei Yao, a další
Vydáno: (2024-01-01)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
Autor: Junlin Shen, a další
Vydáno: (2023-08-01)

Identification of a novel cuproptosis-associated lncRNA model that can improve prognosis prediction in uterine corpus endometrial carcinoma
Autor: Bohan Li, a další
Vydáno: (2023-12-01)

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
Autor: Lin Pang, a další
Vydáno: (2023-03-01)

Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims
Autor: Binxiang Chu, a další
Vydáno: (2022-12-01)

A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer
Autor: Lei Ren, a další
Vydáno: (2023-02-01)

A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
Autor: Mengzhe Zhang, a další
Vydáno: (2023-09-01)